NCT03589729
- Conditions
- Acute Myeloid Leukemia, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Philadelphia Chromosome Positive
Explore clinical trials studying Philadelphia Chromosome Positive. Study availability and eligibility vary by location and protocol.
13 public trials
2 recruiting studies
Philadelphia Chromosome Positive trial results
NCT03263572
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT07178912
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
NCT05007873
- Conditions
- BCR-ABL1 Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia, Bone Marrow Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
NCT03241940
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +29 more
- Locations
-
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
Active, not recruiting
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
NCT01424982
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
NCT03233854
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +22 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
Active, not recruiting
Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia
NCT03512405
- Conditions
- CD19 Positive, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02997761
- Conditions
- Adult B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +16 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT01190930
- Conditions
- Abnormalities, Multiple, Acute Lymphoblastic Leukemia, Adult B Lymphoblastic Lymphoma, +28 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States